The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 17, 2026

Filed:

Jul. 31, 2020
Applicant:

Abbott Diabetes Care Inc., Alameda, CA (US);

Inventors:

Gary A. Hayter, Oakland, CA (US);

Aparajita Bhattacharya, Dublin, CA (US);

Erwin S. Budiman, Fremont, CA (US);

Matthew T. Novak, Oakland, CA (US);

Taihao Jin, Richmond, CA (US);

Marc B. Taub, Mountain View, CA (US);

Jonathan M. Fern, Alameda, CA (US);

Yongjin Xu, San Ramon, CA (US);

Kaiyuan Zhu, San Leandro, CA (US);

Kendall Covington, Oakland, CA (US);

Assignee:

Abbott Diabetes Care Inc., Alameda, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G16H 20/17 (2018.01); A61B 5/00 (2006.01); A61B 5/145 (2006.01); G16H 10/60 (2018.01); G16H 20/60 (2018.01); G16H 40/40 (2018.01); G16H 40/67 (2018.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01); G16H 50/70 (2018.01); G16H 15/00 (2018.01); G16H 70/40 (2018.01);
U.S. Cl.
CPC ...
G16H 20/17 (2018.01); A61B 5/14532 (2013.01); A61B 5/4833 (2013.01); A61B 5/4848 (2013.01); A61B 5/7246 (2013.01); A61B 5/725 (2013.01); A61B 5/7264 (2013.01); A61B 5/7267 (2013.01); G16H 10/60 (2018.01); G16H 20/60 (2018.01); G16H 40/40 (2018.01); G16H 40/67 (2018.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01); G16H 50/70 (2018.01); G16H 15/00 (2018.01); G16H 70/40 (2018.01);
Abstract

Systems, devices and methods are provided for determining a medication dose for a patient or user. The dose determination can account for recent and/or historical analyte levels of the patient or user. The dose determination can also take into account other information about the patient or user, such as physiological information, dietary information, activity, and/or behavior. Many different dose determination embodiments are set forth, pertaining to a wide array of different aspects of the system or environment in which the embodiments can be implemented.


Find Patent Forward Citations

Loading…